Activation of Peroxisome Proliferator–Activated Receptor-β/-δ (PPAR-β/-δ) Ameliorates Insulin Signaling and Reduces SOCS3 Levels by Inhibiting STAT3 in Interleukin-6–Stimulated Adipocytes

OBJECTIVE: It has been suggested that interleukin (IL)-6 is one of the mediators linking obesity-derived chronic inflammation with insulin resistance through activation of STAT3, with subsequent upregulation of suppressor of cytokine signaling 3 (SOCS3). We evaluated whether peroxisome proliferator–...

Descripción completa

Detalles Bibliográficos
Autores principales: Serrano-Marco, Lucía, Rodríguez-Calvo, Ricardo, El Kochairi, Ilhem, Palomer, Xavier, Michalik, Liliane, Wahli, Walter, Vázquez-Carrera, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121427/
https://www.ncbi.nlm.nih.gov/pubmed/21617181
http://dx.doi.org/10.2337/db10-0704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121427/
https://www.ncbi.nlm.nih.gov/pubmed/21617181
http://dx.doi.org/10.2337/db10-0704

Ejemplares similares